The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review

Mara M. van Beusekom; Anne H. Kerkhoven; Mark J.W. Bos; Henk-Jan Guchelaar; Jos M. van den Broek

doi:10.1016/j.drudis.2018.05.013

The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review

Mara M. van Beusekom, Anne H. Kerkhoven, Mark J.W. Bos, Henk-Jan Guchelaar, Jos M. van den Broek

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

This short review provides insight into the extent and effectiveness of patient involvement in the design and evaluation of pictograms to support patient drug information. Pubmed, CINAHL, Cochrane Library, Embase, PsycINFO, Academic Search Premier and Web of Science were searched systematically; the 73 included articles were evaluated with the MMAT. We see that, usually, non-patient end-users are involved in the design of pharmaceutical pictograms - patients are more commonly involved in the final evaluation of pictogram success. Repeated involvement of (non-)patients aids the design of effective pharmaceutical pictograms, although there is limited evidence for such effects on patient perception of drug information or health behaviour.

Original language	English
Pages (from-to)	1312-1318
Number of pages	7
Journal	Drug Discovery Today
Volume	23
Issue number	6
Early online date	7 May 2018
DOIs	https://doi.org/10.1016/j.drudis.2018.05.013
Publication status	Published - Jun 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Drug Labeling
Humans
Patient Participation

Access to Document

10.1016/j.drudis.2018.05.013

van-Beusekom-2019-Extent-and-effects-DDT-1312-CC
Copyright 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Final published version, 325 KBLicence: CC BY

Handle.net

Persistent link

Cite this

@article{c6e6d980e17746429b99e4489886c8e8,

title = "The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review",

abstract = "This short review provides insight into the extent and effectiveness of patient involvement in the design and evaluation of pictograms to support patient drug information. Pubmed, CINAHL, Cochrane Library, Embase, PsycINFO, Academic Search Premier and Web of Science were searched systematically; the 73 included articles were evaluated with the MMAT. We see that, usually, non-patient end-users are involved in the design of pharmaceutical pictograms - patients are more commonly involved in the final evaluation of pictogram success. Repeated involvement of (non-)patients aids the design of effective pharmaceutical pictograms, although there is limited evidence for such effects on patient perception of drug information or health behaviour.",

keywords = "Drug Labeling, Humans, Patient Participation",

author = "\{van Beusekom\}, \{Mara M.\} and Kerkhoven, \{Anne H.\} and Bos, \{Mark J.W.\} and Henk-Jan Guchelaar and \{van den Broek\}, \{Jos M.\}",

year = "2018",

month = jun,

doi = "10.1016/j.drudis.2018.05.013",

language = "English",

volume = "23",

pages = "1312--1318",

journal = "Drug Discovery Today",

issn = "1359-6446",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - The extent and effects of patient involvement in pictogram design for written drug information

T2 - a short systematic review

AU - van Beusekom, Mara M.

AU - Kerkhoven, Anne H.

AU - Bos, Mark J.W.

AU - Guchelaar, Henk-Jan

AU - van den Broek, Jos M.

PY - 2018/6

Y1 - 2018/6

N2 - This short review provides insight into the extent and effectiveness of patient involvement in the design and evaluation of pictograms to support patient drug information. Pubmed, CINAHL, Cochrane Library, Embase, PsycINFO, Academic Search Premier and Web of Science were searched systematically; the 73 included articles were evaluated with the MMAT. We see that, usually, non-patient end-users are involved in the design of pharmaceutical pictograms - patients are more commonly involved in the final evaluation of pictogram success. Repeated involvement of (non-)patients aids the design of effective pharmaceutical pictograms, although there is limited evidence for such effects on patient perception of drug information or health behaviour.

AB - This short review provides insight into the extent and effectiveness of patient involvement in the design and evaluation of pictograms to support patient drug information. Pubmed, CINAHL, Cochrane Library, Embase, PsycINFO, Academic Search Premier and Web of Science were searched systematically; the 73 included articles were evaluated with the MMAT. We see that, usually, non-patient end-users are involved in the design of pharmaceutical pictograms - patients are more commonly involved in the final evaluation of pictogram success. Repeated involvement of (non-)patients aids the design of effective pharmaceutical pictograms, although there is limited evidence for such effects on patient perception of drug information or health behaviour.

KW - Drug Labeling

KW - Humans

KW - Patient Participation

UR - https://www.scopus.com/pages/publications/85047226998

U2 - 10.1016/j.drudis.2018.05.013

DO - 10.1016/j.drudis.2018.05.013

M3 - Review article

C2 - 29747003

SN - 1359-6446

VL - 23

SP - 1312

EP - 1318

JO - Drug Discovery Today

JF - Drug Discovery Today

IS - 6

ER -

The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review

Abstract

UN SDGs

Keywords

Access to Document

Handle.net

Other files and links

Fingerprint

Pharmaceutical pictograms for low-literate patients: understanding, risk of false confidence, and evidence-based design strategies

Low literacy and written drug information: information-seeking, leaflet evaluation and preferences, and roles for images

Cite this